» Articles » PMID: 27956906

Prevalence of Beta-lactam Allergy: a Retrospective Chart Review of Drug Allergy Assessment in a Predominantly Pediatric Population

Overview
Date 2016 Dec 14
PMID 27956906
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Research suggests that 90% of patients labeled beta-lactam allergic are able to tolerate penicillins following further assessment. This study aims to define and describe the frequency of true beta-lactam allergy following allergy patient evaluation in a predominantly pediatric population.

Methods: 306 primary care patients referred between January 2010 and June 2015 were assessed for a suspected beta-lactam allergy. Patient demographics, history and test results were extracted from electronic medical records. Testing performed was based on specialist recommendation following review of patient history.

Results: 34% of the study participants had intradermal testing. Oral challenge was given to 96.7% of the sample. 96% of patients with a prior history of beta-lactam allergy were advised that they could re-introduce beta-lactam antibiotics following evaluation.

Conclusions: Among patients with a documented beta-lactam allergy or a recent history of a reaction there is a low rate of 'true' beta-lactam allergy. Consistent evaluation of beta-lactam antibiotic allergies can reduce rates of broad spectrum antibiotic prescribing, among other harmful consequences.

Citing Articles

Penicillin allergy de-labeling: Adaptation of risk stratification tool for patients and families.

Horwitz S, Shen Y, Erdle S, Elwood C, Mak R, Jacob J World Allergy Organ J. 2024; 17(8):100939.

PMID: 39156596 PMC: 11324811. DOI: 10.1016/j.waojou.2024.100939.


Delabelling beta-lactam allergy.

Molina-Molina G, Garnica Velandia D, Andres-Lopez B, Perales C, Marin-Asensio L, Jurgens Y Front Pharmacol. 2024; 15:1423719.

PMID: 38994200 PMC: 11237397. DOI: 10.3389/fphar.2024.1423719.


True Rate of Allergy among Pediatric Inpatients with Penicillin Allergy Labels (TRIAL).

Kwan N, Kang K, Carr R, Mak R, Roberts A, Jin F Can J Hosp Pharm. 2024; 77(3):e3531.

PMID: 38988874 PMC: 11210598. DOI: 10.4212/cjhp.3531.


Approach for delabeling beta-lactam allergy in children.

Saenz de Santa Maria R, Bogas G, LaBella M, Ariza A, Salas M, Dona I Front Allergy. 2023; 4:1298335.

PMID: 38033918 PMC: 10684789. DOI: 10.3389/falgy.2023.1298335.


.

Wittmer R, Vincent-Boulay O, Barrios J CMAJ. 2023; 195(25):E884-E887.

PMID: 37364912 PMC: 10292960. DOI: 10.1503/cmaj.221266-f.


References
1.
Blanca M, Torres M, Garcia J, Romano A, Mayorga C, de Ramon E . Natural evolution of skin test sensitivity in patients allergic to beta-lactam antibiotics. J Allergy Clin Immunol. 1999; 103(5 Pt 1):918-24. DOI: 10.1016/s0091-6749(99)70439-2. View

2.
Rimawi R, Cook P, Gooch M, Kabchi B, Ashraf M, Rimawi B . The impact of penicillin skin testing on clinical practice and antimicrobial stewardship. J Hosp Med. 2013; 8(6):341-5. DOI: 10.1002/jhm.2036. View

3.
Ponvert C, Perrin Y, Bados-Albiero A, Le Bourgeois M, Karila C, Delacourt C . Allergy to betalactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests. Pediatr Allergy Immunol. 2011; 22(4):411-8. DOI: 10.1111/j.1399-3038.2011.01169.x. View

4.
Macy E . Elective penicillin skin testing and amoxicillin challenge: effect on outpatient antibiotic use, cost, and clinical outcomes. J Allergy Clin Immunol. 1998; 102(2):281-5. DOI: 10.1016/s0091-6749(98)70097-1. View

5.
Goossens H, Ferech M, Vander Stichele R, Elseviers M . Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005; 365(9459):579-87. DOI: 10.1016/S0140-6736(05)17907-0. View